Its important for individuals to discuss with their healthcare provider to determine if semaglutide is a suitable option for their weight management journey
The risk of hypoglycaemia (low blood sugar) is generally low with either medication when used without other glucose-lowering agents, as both have glucose-dependent mechanisms of action
2 3 What should I do with the syringe after use
World Anti-Doping Agency (WADA) IGFDES falls under WADAs prohibited substances list under Peptide Hormones, Growth Factors, and Related Substances (S2 category)
Common side effects when restarting include: Nausea and vomiting (affecting approximately 15-20% of patients according to the SmPC) [1] [4] Diarrhoea or constipation Abdominal discomfort or bloating Reduced appetite (which may be more pronounced if you're still recovering nutritionally) Fatigue or general malaise Injection site reactions (redness, itching, or mild swelling) These effects are generally mild to moderate and self-limiting , resolving within days to a few weeks
After 1 month, individuals receiving the combined supplement exhibited a modest but significant reduction in mean arterial pressure and improved exercise efficiency, characterized by lower heart rate and oxygen consumption during submaximal cycling
